CASC2 and hepatocellular carcinoma: To explore whether CASC2 may influence the survivals of HCC patients, Kaplan–Meier assays were performed, and the results showed that patients with high-CASC2 expression possessed longer overall survival (OS) and disease-free survival (DFS) compared to the low-CASC2 group (P < 0.05).